What is SOPHiA GENETICS?
SOPHiA GENETICS is a Swiss-based company at the forefront of data-driven medicine, specializing in the application of statistical inference, pattern recognition, and machine learning to genomics and radiomics data. Its innovative platform supports healthcare professionals, including geneticists, pathologists, and radiologists, by providing advanced analytical tools to interpret complex biological data. The company's mission is to enhance diagnostic accuracy and personalize treatment strategies within the healthcare industry, positioning itself as a critical enabler of precision medicine.
How much funding has SOPHiA GENETICS raised?
SOPHiA GENETICS has raised a total of $482.8M across 7 funding rounds:
Series A
$3M
Series B
$13.8M
Series C
$15M
Series D
$30M
Series E
$77M
Series F
$110M
Share Placement
$234M
Series A (2013): $3M, investors not publicly disclosed
Series B (2014): $13.8M led by Swisscom Ventures and Endeavour Vision
Series C (2015): $15M, investors not publicly disclosed
Series D (2017): $30M featuring Balderton Capital, 360 Capital Partners, and Invoke Capital
Series E (2019): $77M backed by Idinvest Partners, Balderton Capital, Generation Investment Management, and Alychlo
Series F (2020): $110M with participation from Pictet Group, Hitachi Ventures, Generation Investment Management, aMoon, Eurazeo Growth, Swisscom Ventures, Endeavor Vision, and Credit Suisse
Share Placement (2021): $234M, investors not publicly disclosed
Key Investors in SOPHiA GENETICS
Idinvest Partners
Idinvest Partners is a mid-market private equity firm based in Paris, France, focused on financing and supporting entrepreneurs across various business development stages. Founded in 1997, they provide capital and strategic guidance to growing companies.
Balderton Capital
Balderton Capital is a London-based venture capital firm that invests in early-stage, high-growth technology companies across Europe. They typically lead Seed and Series A rounds, offering support through scale-up and exit phases.
Generation Investment Management
Generation Investment Management is an investment firm focused on long-term investment themes, aiming to generate sustainable financial returns and positive societal impact. They advocate for mobilizing businesses and investors to address global challenges like climate change and inequality.
What's next for SOPHiA GENETICS?
The substantial enterprise-level funding and recent strategic investment indicate SOPHiA GENETICS is poised for significant scaling and further innovation. This capital infusion will likely fuel expansion into new markets, accelerate research and development of its AI-powered diagnostic solutions, and strengthen strategic partnerships within the global healthcare ecosystem. The company's trajectory suggests a continued focus on advancing genomic and radiomic data analysis to drive better patient outcomes and shape the future of personalized healthcare.
See full SOPHiA GENETICS company page
